Literature DB >> 14692198

Prevention of type 2 diabetes: data from recent trials.

A M Kanaya1, K M Narayan.   

Abstract

All four main studies of lifestyle intervention on diabetes incidence found a clear benefit for diet and exercise intervention compared with usual care. Although the study populations differed by race and ethnicity, the mean BMI, and the intensity of the lifestyle intervention provided, all investigators found substantial diabetes risk reduction with modest weight loss and increased physical activity. Results of these trials give health care providers useful and heartening information to share with patients at risk for diabetes. The challenge remains to find feasible and cost-efficient methods to identify people at risk and to deliver effective lifestyle interventions. Findings from trials of pharmacologic agents such as metformin, acarbose, and troglitazone are encouraging; however, the ADA recommends that drug therapy should not be used routinely to prevent diabetes until more information regarding the cost-effectiveness of such intervention is known [20]. Results from trials that found a lower incidence of diabetes among those randomly assigned to angiotensin-converting enzyme inhibitors, statins, or hormone therapy are intriguing but must be viewed with caution because they are based on post hoc analyses. Because it is difficult to conduct randomized controlled trials of major operative procedures such as bariatric surgery, observational studies that compare surgical interventions for weight loss with traditional weight-loss management may be the best evidence available. These studies have the potential for healthy-person bias in that people who choose bariatric surgery may have other healthy behaviors that are often difficult to measure and control for; such behaviors could account for their lower incidence of diabetes. Undeniably, the best test to diagnose those at high risk for diabetes is not yet known. New strategies that identify those with pre-diabetes and that overcome the limitations of the current tests, particularly the 2-hour post-challenge glucose test, are needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14692198     DOI: 10.1016/s0095-4543(03)00034-4

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  8 in total

1.  Diabetes Prevalence by Leisure-, Transportation-, and Occupation-Based Physical Activity Among Racially/Ethnically Diverse U.S. Adults.

Authors:  Anna A Divney; Rosenda Murillo; Fatima Rodriguez; Chloe A Mirzayi; Emma K Tsui; Sandra E Echeverria
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

2.  Long-term clinical effect of Tangyiping Granules () on patients with impaired glucose tolerance.

Authors:  Yan-Qin Huang; Qing-Feng Yang; Hua Wang; Yun-Sheng Xu; Wei Peng; Yue-Hua Jiang
Journal:  Chin J Integr Med       Date:  2016-09-11       Impact factor: 1.978

Review 3.  Achieving euglycaemia in women with gestational diabetes mellitus: current options for screening, diagnosis and treatment.

Authors:  Lois Jovanovic
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Type 2 diabetes risk forecasting from EMR data using machine learning.

Authors:  Subramani Mani; Yukun Chen; Tom Elasy; Warren Clayton; Joshua Denny
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

Review 5.  Anatomy of culturally sensitive interventions promoting nutrition and exercise in hispanics: a critical examination of existing literature.

Authors:  Nelda Mier; Marcia G Ory; Alvaro A Medina
Journal:  Health Promot Pract       Date:  2009-02-04

6.  Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats.

Authors:  Bethany P Cummings; Kimber L Stanhope; James L Graham; Denis G Baskin; Steven C Griffen; Cecilia Nilsson; Anette Sams; Lotte B Knudsen; Kirsten Raun; Peter J Havel
Journal:  Diabetes       Date:  2010-07-09       Impact factor: 9.461

7.  The improvement of quality of life in patients treated with bariatric surgery in Korea.

Authors:  Sung-Hee Oh; Hyun Jin Song; Jin-Won Kwon; Do-Joong Park; Yeon-Ji Lee; Hyejin Chun; Sunyoung Kim; Kyung-Won Shim
Journal:  J Korean Surg Soc       Date:  2013-02-27

8.  Mexican Americans with type 2 diabetes: perspectives on definitions, motivators, and programs of physical activity.

Authors:  Nelda Mier; Alvaro A Medina; Marcia G Ory
Journal:  Prev Chronic Dis       Date:  2007-03-15       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.